(Created page with "{{Infobox drug reference | trade_names = | drug_class = | drug_class_color = | uses = | contraindications = | routes = | dosage = }} Provide a brief summary of this dr...")
 
Line 1: Line 1:
{{Infobox drug reference
{{Infobox drug reference
| trade_names =  
| trade_names = Brevibloc
| drug_class =  
| image_file = Esmolol.svg
| drug_class_color =  
| drug_class = Beta blocker
| drug_class_color = cardiovascular_antagonist
| uses =  
| uses =  
| contraindications =  
| contraindications =  
| routes =  
| routes = Intravenous
| dosage =  
| dosage =  
| mechanism = Beta-1 antagonism
| adverse_effects =
| time_onset =
| duration =
| metabolism =
| halflife_redistribution =
| halflife_elimination =
| clearance =
| protein_binding =
}}
}}


Line 36: Line 46:


[[Category:Drug reference]]
[[Category:Drug reference]]
[[Category:Adrenergic receptor modulators]]
[[Category:Beta blockers]]
[[Category:Beta-1 selective antagonists]]

Revision as of 16:03, 12 November 2021

Esmolol
Trade names

Brevibloc

Esmolol.svg
Clinical data
Drug class

Beta blocker

Routes of administration

Intravenous

Pharmacodynamics
Mechanism of action

Beta-1 antagonism

Pharmacokinetics
Physical and chemical data
Article quality
Editor rating
Unrated
User likes
0

Provide a brief summary of this drug here.

Uses

Contraindications

Absolute contraindications

Precautions

Pharmacology

Pharmacodynamics

Mechanism of action

Adverse effects

Pharmacokinetics

Chemistry and formulation

History

References